The firm also released pro forma results for its Q1 — reflecting the dispositions of the specialty product lines — showing $2.1 million less in revenues than previously reported, while its cash position increased 45 percent.
The CRADA with Armed Forces Institute of Pathology, the American Registry of Pathology, and the Department of Veterans Affairs is to develop pressure-based sample prep methods to improve the quality and yield of biomolecular extractions from FFPE tissue.
At last week's Sample Prep 2010 meeting in Baltimore, Md., microfluidics, integration, and automation were oft-cited as future market drivers in the area of sample prep for virus, toxin, and pathogen detection.
The technology lyses cells, extracts nucleic acids, and performs whole-genome amplification to generate starting material from trace specimens for whole-genome sequence analysis; and has already been tested with sequencing platforms from Roche 454 and Pacific Biosciences.
The Swiss firm said that it will use the cash to accelerate development and validation of the first version of its forthcoming molecular diagnostics platform, which will incorporate nucleic acid sample prep technology recently acquired from Royal Philips Electronics.